You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Factor IX

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hemophilia A, Hemophilia B Trial in Worldwide (fitusiran, factor concentrates)

Completed
Has Results
  • Hemophilia A
  • Hemophilia B
  • Little Rock, Arkansas
  • +63 more
Mar 15, 2022

Mutation p.Ile112Thr : Discrepancy Between Factor IX Level and

Unknown status
  • Hemophilia B
  • data collection
  • Dijon, France
    CHU Dijon Bourgogne
May 9, 2019

Hemophilia B Trial in Australia, United States (SPK-9001)

Completed
Has Results
  • Hemophilia B
  • SPK-9001
  • Sacramento, California
  • +9 more
Jun 3, 2020

Hemophilia A, Hemophilia B Trial in Worldwide (Fitusiran (SAR439774))

Active, not recruiting
  • Hemophilia A
  • Hemophilia B
  • Fitusiran (SAR439774)
  • Ann Arbor, Michigan
  • +11 more
Aug 4, 2022

Patterns of Hemophilia Care in Assiut Children Patients

Not yet recruiting
  • Hemophilia A
  • Hemophilia B
    • (no location specified)
    Jul 29, 2023

    Hemophilia B, Hemophilia A Trial in Worldwide (Standard of Care FIX Replacement therapy, Standard of Care FVIII Replacement

    Recruiting
    • Hemophilia B
    • Hemophilia A
    • Standard of Care FIX Replacement therapy
    • Standard of Care FVIII Replacement therapy
    • Palo Alto, California
    • +77 more
    Dec 29, 2022

    Hemophilia A Trial in Worldwide (SPK-8011)

    Recruiting
    • Hemophilia A
    • SPK-8011
    • Sacramento, California
    • +18 more
    Jul 15, 2022

    Real-world Effectiveness and Usage of Alprolix in Haemophilia B

    Completed
    • Haemophilia B
    • Bordeaux, France
    • +17 more
    Jan 11, 2023

    Hemophilia B Without Inhibitor Trial (Low dose KL001, Middle dose KL001, High dose KL001)

    Not yet recruiting
    • Hemophilia B Without Inhibitor
    • Low dose KL001
    • +2 more
    • (no location specified)
    Nov 5, 2023

    Hemophilia B Without Inhibitor Trial (Low dose KL001, Middle dose KL001, High dose KL001)

    Not yet recruiting
    • Hemophilia B Without Inhibitor
    • Low dose KL001
    • +2 more
    • (no location specified)
    Nov 5, 2023

    Hemophilia B, Blood Coagulation Disorders, Inherited, Blood Coagulation Disorder Trial in Worldwide

    Recruiting
    • Hemophilia B
    • +3 more
      • Phoenix, Arizona
      • +55 more
      Dec 6, 2021

      Hemophilia B Trial in Tianjin (Single dose intravenous injection of BBM-H901)

      Active, not recruiting
      • Hemophilia B
      • Single dose intravenous injection of BBM-H901
      • Tianjin, Tianjin, China
        Institute of Hematology & Blood Diseases Hospital
      Dec 12, 2021

      Coagulation, Inflammation and Vessels in Chronic Liver Disease

      Not yet recruiting
      • Chronic Liver Diseases
      • Coagulation
      • biomarker assay
      • (no location specified)
      May 9, 2023

      Factor Product Utilization and Health Outcomes in Hemophilia

      Completed
      • Hemophilia A, Congenital
      • Hemophilia B, Congenital
        • Vancouver, British Columbia, Canada
          BC Hemophilia Adult Program
        Apr 26, 2021

        Hemophilia B Trial in Tianjin (ZS801)

        Not yet recruiting
        • Hemophilia B
        • ZS801
        • Tianjin, Tianjin, China
          Institute of Hematology & Blood Diseases Hospital
        Nov 24, 2022

        Hemophilia B Trial in Tianjin (ZS801)

        Not yet recruiting
        • Hemophilia B
        • ZS801
        • Tianjin, Tianjin, China
          Institute of Hematology & Blood Diseases Hospital
        Dec 5, 2022

        Hemophilia A, Hemophilia B Trial in Worldwide (fitusiran, Bypassing agents)

        Completed
        Has Results
        • Hemophilia A
        • Hemophilia B
        • Phoenix, Arizona
        • +57 more
        Mar 15, 2022

        Duchenne Muscular Dystrophy Trial in Chengdu (JWK007 Single intravenous infusion administration)

        Recruiting
        • Duchenne Muscular Dystrophy
        • JWK007 Single intravenous infusion administration
        • Chengdu, Sichuan, China
          West China Hospital, Sichuan University
        Oct 29, 2023

        Real-world Usage and Effectiveness of Elocta and Alprolix in

        Completed
        • Haemophilia A
        • Haemophilia B
        • Berlin, Germany
        • +21 more
        May 3, 2022

        Reliability and Validity of the Turkish Version of the PedHAL

        Not yet recruiting
        • Hemophilia
        • +2 more
          • Gaziantep, Şahinbey, Turkey
            Hasan Kalyoncu University
          Jun 2, 2023

          Hemophilia B Trial in Philadelphia, Pittsburgh, Camperdown (AAV8-hFIX19)

          Terminated
          • Hemophilia B
          • AAV8-hFIX19
          • Philadelphia, Pennsylvania
          • +2 more
          Mar 11, 2019

          Observatory of Patients With Haemophilia B Treated by IdElvion®

          Recruiting
          • Haemophilia B
            • Annecy, France
            • +23 more
            Oct 4, 2022

            Trauma Trial (4 factor Prothrombin Complex Concentrates)

            Not yet recruiting
            • Trauma
            • 4 factor Prothrombin Complex Concentrates
            • (no location specified)
            Feb 21, 2023

            Severe Hemophilia A, Osteoporosis Trial in Bron (radiation, biological, other)

            Recruiting
            • Severe Hemophilia A
            • Osteoporosis
            • HR-pQCT
            • +3 more
            • Bron, France
              Hôpital Cardio-Vasculaire et Pneumologique
            Feb 22, 2022

            Study Medicines Called Giroctocogene Fitelparvovec and

            Recruiting
            • Hemophilia A
            • Hemophilia B
            • Testing of hepatic AAV Vector integration
            • Madison, Mississippi
              Mississippi Center For Advanced Medicine
            Dec 1, 2022